English
简体中文
Total: £ 56.28
Published Date: 2025-11-05 | Pages: 139 | Tables: 139 | Service & Software
The global Pharmaceutical Distribution Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
A pharmaceutical distribution service is service that specializes in the storage, transportation, and delivery of pharmaceutical products to healthcare facilities, pharmacies, and other healthcare providers. These services play a crucial role in ensuring that medications and medical supplies are delivered safely and efficiently to where they are needed. Pharmaceutical distribution services must adhere to strict regulations and quality standards to ensure the safe handling and delivery of pharmaceutical products. They work closely with pharmaceutical manufacturers, wholesalers, and healthcare providers to ensure timely and accurate delivery of medications and medical supplies.
From a downstream perspective, Pharmaceutical Manufacturing Company accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Distribution Service leading manufacturers including Medical Logistics, Expak Logistics, AmerisourceBergen, McKesson, SIS Shipping, Cardinal Health, PCI Services, Morris & Dickson Co, Pharma Logistics, World Courier, etc., dominate supply; the top five capture approximately % of global revenue, with Medical Logistics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Distribution Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medical Logistics
Expak Logistics
AmerisourceBergen
McKesson
SIS Shipping
Cardinal Health
PCI Services
Morris & Dickson Co
Pharma Logistics
World Courier
Besse Medical
West Pharmaceutical Services , Inc
Pharma Distribution & Fulfillment Services
Segment by Type
Cold Chain Pharmaceutical Distribution Service
Dangerous Goods Pharmaceutical Distribution Service
Controlled Substance Pharmaceutical Distribution Service
Others
Segment by Application
Pharmaceutical Manufacturing Company
Pharmaceutical Distribution Company
Medical Institution
Pharmacy
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Pharmaceutical Distribution Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Pharmaceutical Distribution Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Distribution Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cold Chain Pharmaceutical Distribution Service
1.2.3 Dangerous Goods Pharmaceutical Distribution Service
1.2.4 Controlled Substance Pharmaceutical Distribution Service
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Distribution Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Manufacturing Company
1.3.3 Pharmaceutical Distribution Company
1.3.4 Medical Institution
1.3.5 Pharmacy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Distribution Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Distribution Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Distribution Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Distribution Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cold Chain Pharmaceutical Distribution Service Market Size by Players
3.3.2 Dangerous Goods Pharmaceutical Distribution Service Market Size by Players
3.3.3 Controlled Substance Pharmaceutical Distribution Service Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Pharmaceutical Distribution Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Distribution Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Distribution Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Distribution Service Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Distribution Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Distribution Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Distribution Service Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Distribution Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Distribution Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Distribution Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Distribution Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Distribution Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Distribution Service Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Distribution Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Distribution Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Distribution Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Distribution Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Distribution Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medical Logistics
11.1.1 Medical Logistics Corporation Information
11.1.2 Medical Logistics Business Overview
11.1.3 Medical Logistics Pharmaceutical Distribution Service Product Features and Attributes
11.1.4 Medical Logistics Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.1.5 Medical Logistics Pharmaceutical Distribution Service Revenue by Product in 2024
11.1.6 Medical Logistics Pharmaceutical Distribution Service Revenue by Application in 2024
11.1.7 Medical Logistics Pharmaceutical Distribution Service Revenue by Geographic Area in 2024
11.1.8 Medical Logistics Pharmaceutical Distribution Service SWOT Analysis
11.1.9 Medical Logistics Recent Developments
11.2 Expak Logistics
11.2.1 Expak Logistics Corporation Information
11.2.2 Expak Logistics Business Overview
11.2.3 Expak Logistics Pharmaceutical Distribution Service Product Features and Attributes
11.2.4 Expak Logistics Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.2.5 Expak Logistics Pharmaceutical Distribution Service Revenue by Product in 2024
11.2.6 Expak Logistics Pharmaceutical Distribution Service Revenue by Application in 2024
11.2.7 Expak Logistics Pharmaceutical Distribution Service Revenue by Geographic Area in 2024
11.2.8 Expak Logistics Pharmaceutical Distribution Service SWOT Analysis
11.2.9 Expak Logistics Recent Developments
11.3 AmerisourceBergen
11.3.1 AmerisourceBergen Corporation Information
11.3.2 AmerisourceBergen Business Overview
11.3.3 AmerisourceBergen Pharmaceutical Distribution Service Product Features and Attributes
11.3.4 AmerisourceBergen Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.3.5 AmerisourceBergen Pharmaceutical Distribution Service Revenue by Product in 2024
11.3.6 AmerisourceBergen Pharmaceutical Distribution Service Revenue by Application in 2024
11.3.7 AmerisourceBergen Pharmaceutical Distribution Service Revenue by Geographic Area in 2024
11.3.8 AmerisourceBergen Pharmaceutical Distribution Service SWOT Analysis
11.3.9 AmerisourceBergen Recent Developments
11.4 McKesson
11.4.1 McKesson Corporation Information
11.4.2 McKesson Business Overview
11.4.3 McKesson Pharmaceutical Distribution Service Product Features and Attributes
11.4.4 McKesson Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.4.5 McKesson Pharmaceutical Distribution Service Revenue by Product in 2024
11.4.6 McKesson Pharmaceutical Distribution Service Revenue by Application in 2024
11.4.7 McKesson Pharmaceutical Distribution Service Revenue by Geographic Area in 2024
11.4.8 McKesson Pharmaceutical Distribution Service SWOT Analysis
11.4.9 McKesson Recent Developments
11.5 SIS Shipping
11.5.1 SIS Shipping Corporation Information
11.5.2 SIS Shipping Business Overview
11.5.3 SIS Shipping Pharmaceutical Distribution Service Product Features and Attributes
11.5.4 SIS Shipping Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.5.5 SIS Shipping Pharmaceutical Distribution Service Revenue by Product in 2024
11.5.6 SIS Shipping Pharmaceutical Distribution Service Revenue by Application in 2024
11.5.7 SIS Shipping Pharmaceutical Distribution Service Revenue by Geographic Area in 2024
11.5.8 SIS Shipping Pharmaceutical Distribution Service SWOT Analysis
11.5.9 SIS Shipping Recent Developments
11.6 Cardinal Health
11.6.1 Cardinal Health Corporation Information
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Pharmaceutical Distribution Service Product Features and Attributes
11.6.4 Cardinal Health Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.6.5 Cardinal Health Recent Developments
11.7 PCI Services
11.7.1 PCI Services Corporation Information
11.7.2 PCI Services Business Overview
11.7.3 PCI Services Pharmaceutical Distribution Service Product Features and Attributes
11.7.4 PCI Services Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.7.5 PCI Services Recent Developments
11.8 Morris & Dickson Co
11.8.1 Morris & Dickson Co Corporation Information
11.8.2 Morris & Dickson Co Business Overview
11.8.3 Morris & Dickson Co Pharmaceutical Distribution Service Product Features and Attributes
11.8.4 Morris & Dickson Co Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.8.5 Morris & Dickson Co Recent Developments
11.9 Pharma Logistics
11.9.1 Pharma Logistics Corporation Information
11.9.2 Pharma Logistics Business Overview
11.9.3 Pharma Logistics Pharmaceutical Distribution Service Product Features and Attributes
11.9.4 Pharma Logistics Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.9.5 Pharma Logistics Recent Developments
11.10 World Courier
11.10.1 World Courier Corporation Information
11.10.2 World Courier Business Overview
11.10.3 World Courier Pharmaceutical Distribution Service Product Features and Attributes
11.10.4 World Courier Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Besse Medical
11.11.1 Besse Medical Corporation Information
11.11.2 Besse Medical Business Overview
11.11.3 Besse Medical Pharmaceutical Distribution Service Product Features and Attributes
11.11.4 Besse Medical Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.11.5 Besse Medical Recent Developments
11.12 West Pharmaceutical Services , Inc
11.12.1 West Pharmaceutical Services , Inc Corporation Information
11.12.2 West Pharmaceutical Services , Inc Business Overview
11.12.3 West Pharmaceutical Services , Inc Pharmaceutical Distribution Service Product Features and Attributes
11.12.4 West Pharmaceutical Services , Inc Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.12.5 West Pharmaceutical Services , Inc Recent Developments
11.13 Pharma Distribution & Fulfillment Services
11.13.1 Pharma Distribution & Fulfillment Services Corporation Information
11.13.2 Pharma Distribution & Fulfillment Services Business Overview
11.13.3 Pharma Distribution & Fulfillment Services Pharmaceutical Distribution Service Product Features and Attributes
11.13.4 Pharma Distribution & Fulfillment Services Pharmaceutical Distribution Service Revenue and Gross Margin (2020-2025)
11.13.5 Pharma Distribution & Fulfillment Services Recent Developments
12 Pharmaceutical Distribution ServiceIndustry Chain Analysis
12.1 Pharmaceutical Distribution Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Distribution Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Distribution Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Pharmaceutical Distribution Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Distribution Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Distribution Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Distribution Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pharmaceutical Distribution Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Distribution Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pharmaceutical Distribution Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Distribution Service as of 2024)
Table 11. Global Pharmaceutical Distribution Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pharmaceutical Distribution Service Companies Headquarters
Table 13. Global Pharmaceutical Distribution Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pharmaceutical Distribution Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Distribution Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pharmaceutical Distribution Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Distribution Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pharmaceutical Distribution Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pharmaceutical Distribution Service Growth Accelerators and Market Barriers
Table 25. North America Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pharmaceutical Distribution Service Growth Accelerators and Market Barriers
Table 27. Europe Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pharmaceutical Distribution Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pharmaceutical Distribution Service Investment Opportunities and Key Challenges
Table 31. Central and South America Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pharmaceutical Distribution Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pharmaceutical Distribution Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Medical Logistics Corporation Information
Table 35. Medical Logistics Description and Major Businesses
Table 36. Medical Logistics Product Features and Attributes
Table 37. Medical Logistics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Medical Logistics Revenue Proportion by Product in 2024
Table 39. Medical Logistics Revenue Proportion by Application in 2024
Table 40. Medical Logistics Revenue Proportion by Geographic Area in 2024
Table 41. Medical Logistics Pharmaceutical Distribution Service SWOT Analysis
Table 42. Medical Logistics Recent Developments
Table 43. Expak Logistics Corporation Information
Table 44. Expak Logistics Description and Major Businesses
Table 45. Expak Logistics Product Features and Attributes
Table 46. Expak Logistics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Expak Logistics Revenue Proportion by Product in 2024
Table 48. Expak Logistics Revenue Proportion by Application in 2024
Table 49. Expak Logistics Revenue Proportion by Geographic Area in 2024
Table 50. Expak Logistics Pharmaceutical Distribution Service SWOT Analysis
Table 51. Expak Logistics Recent Developments
Table 52. AmerisourceBergen Corporation Information
Table 53. AmerisourceBergen Description and Major Businesses
Table 54. AmerisourceBergen Product Features and Attributes
Table 55. AmerisourceBergen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. AmerisourceBergen Revenue Proportion by Product in 2024
Table 57. AmerisourceBergen Revenue Proportion by Application in 2024
Table 58. AmerisourceBergen Revenue Proportion by Geographic Area in 2024
Table 59. AmerisourceBergen Pharmaceutical Distribution Service SWOT Analysis
Table 60. AmerisourceBergen Recent Developments
Table 61. McKesson Corporation Information
Table 62. McKesson Description and Major Businesses
Table 63. McKesson Product Features and Attributes
Table 64. McKesson Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. McKesson Revenue Proportion by Product in 2024
Table 66. McKesson Revenue Proportion by Application in 2024
Table 67. McKesson Revenue Proportion by Geographic Area in 2024
Table 68. McKesson Pharmaceutical Distribution Service SWOT Analysis
Table 69. McKesson Recent Developments
Table 70. SIS Shipping Corporation Information
Table 71. SIS Shipping Description and Major Businesses
Table 72. SIS Shipping Product Features and Attributes
Table 73. SIS Shipping Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. SIS Shipping Revenue Proportion by Product in 2024
Table 75. SIS Shipping Revenue Proportion by Application in 2024
Table 76. SIS Shipping Revenue Proportion by Geographic Area in 2024
Table 77. SIS Shipping Pharmaceutical Distribution Service SWOT Analysis
Table 78. SIS Shipping Recent Developments
Table 79. Cardinal Health Corporation Information
Table 80. Cardinal Health Description and Major Businesses
Table 81. Cardinal Health Product Features and Attributes
Table 82. Cardinal Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Cardinal Health Recent Developments
Table 84. PCI Services Corporation Information
Table 85. PCI Services Description and Major Businesses
Table 86. PCI Services Product Features and Attributes
Table 87. PCI Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. PCI Services Recent Developments
Table 89. Morris & Dickson Co Corporation Information
Table 90. Morris & Dickson Co Description and Major Businesses
Table 91. Morris & Dickson Co Product Features and Attributes
Table 92. Morris & Dickson Co Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Morris & Dickson Co Recent Developments
Table 94. Pharma Logistics Corporation Information
Table 95. Pharma Logistics Description and Major Businesses
Table 96. Pharma Logistics Product Features and Attributes
Table 97. Pharma Logistics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Pharma Logistics Recent Developments
Table 99. World Courier Corporation Information
Table 100. World Courier Description and Major Businesses
Table 101. World Courier Product Features and Attributes
Table 102. World Courier Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. World Courier Recent Developments
Table 104. Besse Medical Corporation Information
Table 105. Besse Medical Description and Major Businesses
Table 106. Besse Medical Product Features and Attributes
Table 107. Besse Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Besse Medical Recent Developments
Table 109. West Pharmaceutical Services , Inc Corporation Information
Table 110. West Pharmaceutical Services , Inc Description and Major Businesses
Table 111. West Pharmaceutical Services , Inc Product Features and Attributes
Table 112. West Pharmaceutical Services , Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. West Pharmaceutical Services , Inc Recent Developments
Table 114. Pharma Distribution & Fulfillment Services Corporation Information
Table 115. Pharma Distribution & Fulfillment Services Description and Major Businesses
Table 116. Pharma Distribution & Fulfillment Services Product Features and Attributes
Table 117. Pharma Distribution & Fulfillment Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Pharma Distribution & Fulfillment Services Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Distribution Service Product Picture
Figure 2. Global Pharmaceutical Distribution Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cold Chain Pharmaceutical Distribution Service Product Picture
Figure 4. Dangerous Goods Pharmaceutical Distribution Service Product Picture
Figure 5. Controlled Substance Pharmaceutical Distribution Service Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pharmaceutical Distribution Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Pharmaceutical Manufacturing Company
Figure 9. Pharmaceutical Distribution Company
Figure 10. Medical Institution
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Pharmaceutical Distribution Service Report Years Considered
Figure 14. Global Pharmaceutical Distribution Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 16. Global Pharmaceutical Distribution Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Pharmaceutical Distribution Service Revenue Market Share by Region (2020-2031)
Figure 18. Global Pharmaceutical Distribution Service Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Cold Chain Pharmaceutical Distribution Service Revenue Market Share by Player in 2024
Figure 21. Dangerous Goods Pharmaceutical Distribution Service Revenue Market Share by Player in 2024
Figure 22. Controlled Substance Pharmaceutical Distribution Service Revenue Market Share by Player in 2024
Figure 23. Others Revenue Market Share by Player in 2024
Figure 24. Global Pharmaceutical Distribution Service Revenue Market Share by Type (2020-2031)
Figure 25. Global Pharmaceutical Distribution Service Revenue Market Share by Application (2020-2031)
Figure 26. North America Pharmaceutical Distribution Service Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Pharmaceutical Distribution Service Revenue (US$ Million) in 2024
Figure 28. North America Pharmaceutical Distribution Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Pharmaceutical Distribution Service Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Pharmaceutical Distribution Service Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Pharmaceutical Distribution Service Revenue (US$ Million) in 2024
Figure 35. Europe Pharmaceutical Distribution Service Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Pharmaceutical Distribution Service Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 38. France Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Pharmaceutical Distribution Service Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Pharmaceutical Distribution Service Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Pharmaceutical Distribution Service Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Pharmaceutical Distribution Service Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 50. India Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Pharmaceutical Distribution Service Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Pharmaceutical Distribution Service Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Pharmaceutical Distribution Service Revenue (US$ Million) in 2024
Figure 58. Central and South America Pharmaceutical Distribution Service Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Pharmaceutical Distribution Service Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Pharmaceutical Distribution Service Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Pharmaceutical Distribution Service Revenue (US$ Million) in 2024
Figure 64. South America Pharmaceutical Distribution Service Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Pharmaceutical Distribution Service Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Pharmaceutical Distribution Service Revenue (2020-2025) & (US$ Million)
Figure 70. Pharmaceutical Distribution Service Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
